Combination versus Monotherapy as Initial Treatment in Hypertension

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Monotherapy normalizes blood pressure in less than 25% of hypertension patients.
• Essential hypertension has a multifactorial pathogenesis, necessitating diverse therapeutic strategies.

Purpose of the Study:

• To evaluate the efficacy and advantages of combination therapy over traditional monotherapy for hypertension.
• To highlight the benefits of initial low-dose combination therapy in managing essential hypertension.

Main Methods:

• Review of clinical trials comparing combination therapy with stepped-care and sequential monotherapy.
• Analysis of additive effects, neutralization of counter-regulatory responses, and organ-protective effects.

Main Results:

• Combination therapy improves blood pressure reduction through additive effects and counteracting compensatory reactions.
• Lower doses in combination therapy reduce the number and severity of adverse effects.
• Clinical trials show initial low-dose combination therapy is superior to stepped-care and sequential monotherapy.

Conclusions:

• Initial low-dose combination therapy is recommended for hypertension management.
• Combination therapy offers improved efficacy, safety, cost-effectiveness, and patient compliance.
• This strategy is more suitable for the multifactorial nature of essential hypertension.